Article
NT-proBNP as a surrogate for unknown heart failure and its predictive power for peripheral artery disease outcome and phenotype.
Scientific reports - 17 May 2023
Zierfuss Bernhard, Feldscher Anna, Höbaus Clemens, Hannes Antonia, Koppensteiner Renate, Schernthaner Gerit-Holger
Abstract excerpt
Patients with peripheral artery disease (PAD) are at high risk of excess mortality despite major improvements in multimodal pharmacotherapy for cardiovascular disease. However, little is known about co-prevalences and implications for the combination of heart failure (HF) and PAD. Thus, NT-proBNP as a suggested surrogate for HF was evaluated in symptomatic PAD regarding long-term mortality. After approval by the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.